About this item:

985 Views | 738 Downloads

Author Notes:

Correspondence: sshultz@unimelb.edu.au

SRS, TOB, DGS and BDS conceptualized and designed the study.

SRS completed all surgeries and injuries.

KMW completed all injections and behavioural testing.

KMW, MS and EO completed immunofluorescence and lipid peroxidation assays.

KMW and DW completed MRI analysis.

All authors were involved in data interpretation and writing the manuscript. All authors read and approved the final manuscript.

We would like to thank Dr. Iqbal Sayeed (Emory University) for his contributions towards this project.

DGS along with Emory University retains patents related to the use of progesterone in TBI and certain forms of CNS tumours but has no financial gains, royalties or licensing agreements from research on progesterone.

None of the other authors have competing interests.

Subjects:

Research Funding:

This study was funded by a grant to SRS from the National Health and Medical Research Council (NHMRC #1062653) and fellowships to SRS from the Canadian Institute of Health Research and NHMRC.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Immunology
  • Neurosciences
  • Neurosciences & Neurology
  • Concussion
  • Chronic traumatic encephalopathy
  • Animal model
  • DTI
  • MRI
  • Treatment
  • Microglia
  • Macrophages
  • Astrogliosis
  • Lipid peroxidation
  • PROFESSIONAL FOOTBALL PLAYERS
  • FLUID PERCUSSION INJURY
  • HIGH-DOSE PROGESTERONE
  • RECURRENT CONCUSSION
  • ANIMAL-MODEL
  • BEHAVIORAL IMPAIRMENTS
  • INFLAMMATORY RESPONSE
  • COGNITIVE IMPAIRMENT
  • SYNAPTIC PLASTICITY
  • LIPID-PEROXIDATION

Progesterone treatment reduces neuroinflammation, oxidative stress and brain damage and improves long-term outcomes in a rat model of repeated mild traumatic brain injury

Tools:

Journal Title:

Journal of Neuroinflammation

Volume:

Volume 12, Number 1

Publisher:

, Pages 238-238

Type of Work:

Article | Final Publisher PDF

Abstract:

Background: Repeated mild traumatic brain injuries, such as concussions, may result in cumulative brain damage, neurodegeneration and other chronic neurological impairments. There are currently no clinically available treatment options known to prevent these consequences. However, growing evidence implicates neuroinflammation and oxidative stress in the pathogenesis of repetitive mild brain injuries; thus, these may represent potential therapeutic targets. Progesterone has been demonstrated to have potent anti-inflammatory and anti-oxidant properties after brain insult; therefore, here, we examined progesterone treatment in rats given repetitive mild brain injuries via the repeated mild fluid percussion injury model. Methods: Male Long-Evans rats were assigned into four groups: sham injury + vehicle treatment, sham injury + progesterone treatment (8 mg/kg/day), repeated mild fluid percussion injuries + vehicle treatment, and repeated mild fluid percussion injuries + progesterone treatment. Rats were administered a total of three injuries, with each injury separated by 5 days. Treatment was initiated 1 h after the first injury, then administered daily for a total of 15 days. Rats underwent behavioural testing at 12-weeks post-treatment to assess cognition, motor function, anxiety and depression. Brains were then dissected for analysis of markers for neuroinflammation and oxidative stress. Ex vivo MRI was conducted in order to examine structural brain damage and white matter integrity. Results: Repeated mild fluid percussion injuries + progesterone treatment rats showed significantly reduced cognitive and sensorimotor deficits compared to their vehicle-treated counterparts at 12-weeks post-treatment. Progesterone treatment significantly attenuated markers of neuroinflammation and oxidative stress in rats given repeated mild fluid percussion injuries, with concomitant reductions in grey and white matter damage as indicated by MRI. Conclusions: These findings implicate neuroinflammation and oxidative stress in the pathophysiological aftermath of mild brain injuries and suggest that progesterone may be a viable treatment option to mitigate these effects and their detrimental consequences.

Copyright information:

© Webster et al. 2015

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/).

Creative Commons License

Export to EndNote